SOLAREA BIO
Solarea Bio is a biotech company that develops microbial therapeutics aimed to treat indications derived from chronic inflammation to aid human health. It specializes in the research and development of therapeutics that are derived from natural sources and are aimed to treat indications derived from chronic inflammation, enabling hospitals to provide medicinal drugs for improved quality of life. The company generates a large database of the complete genomic sequences of microbes derived from he... althy foods. Using computational approaches, Solarea generates synergistic combinations of bacteria, fungi, and prebiotic fibers with powerful anti-inflammatory capabilities to address specific chronic conditions that afflict large numbers of people. These have been validated in-vitro and in-vivo in preclinical mouse models. Its first application aims to aid in the dietary management of the metabolic processes that cause osteopenia and osteoporosis in postmenopausal women. This provides a nature-based solution to improving women’s health and well-being. The Cambridge, Massachusetts-based company was established in 2017 by Eric Schott, Gerardo Toledo, and Jillian DeWalt.
SOLAREA BIO
Social Links:
Industry:
Biotechnology Health Care Therapeutics Wellness
Founded:
2017-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.solareabio.com
Total Employee:
1+
Status:
Active
Total Funding:
11.2 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics
Similar Organizations
Akebia Therapeutics
Akebia Therapeutics develops treatments for ischemia and vascular diseases.
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Arvinas
Arvinas advances therapies degrading disease-causing proteins for life-threatening diseases, from discovery to commercialization.
Edifice Health
Edifice Health is a immunological health and personalized nutrition company offering a novel metric of inflammatory health.
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
GenoPalate
GenoPalate analyzes genetic data, demographics and lifestyle information to deliver personalized insights for optimal healthy eating.
Inceptor Bio
Inceptor Bio develops cell therapy solutions to cure difficult-to-treat cancers.
LUCA Biologics
Live biotherapeutics targeting the vaginal microbiome for unmet medical needs in urogenital and reproductive health.
Newomics
Newomics commercializes innovative and integrative platforms and solutions for personalized healthcare.
Pandion Therapeutics
Pandion Therapeutics develops innovative modular proteins, antibodies, and bispecifics for autoimmune and inflammatory diseases.
Current Advisors List
Current Employees Featured
Founder
Investors List
Bold Capital Partners
Bold Capital Partners investment in Series A - Solarea Bio
GISEV Family Office
GISEV Family Office investment in Series A - Solarea Bio
S2G Ventures
S2G Ventures investment in Series A - Solarea Bio
Viking Global Investors
Viking Global Investors investment in Series A - Solarea Bio
Social Starts
Social Starts investment in Seed Round - Solarea Bio
Rising Tide
Rising Tide investment in Seed Round - Solarea Bio
Official Site Inspections
http://www.solareabio.com
- Host name: 76.76.21.21
- IP address: 76.76.21.21
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Solarea Bio"
Solarea
Clinically validated to slow bone loss (clinical study pending peer review & publication)See details»
Solarea Bio - Crunchbase Company Profile & Funding
Contact Email [email protected] Solarea Bio is a biotech company that develops microbial …See details»
Solarea Bio - LinkedIn
Solarea Bio | 1,826 followers on LinkedIn. Solarea Bio is a clinical-stage biotechnology …See details»
Solarea Bio Company Profile 2025: Valuation, Funding …
Solarea Bio General Information Description. Developer of microbiome-based therapeutics designed to improve human health. The company's strain catalog …See details»
Solarea Bio Company Profile | Management and Employees List
[email protected]: Solarea Bio Top Competitors. Company Employees Revenue Top …See details»
Solarea Bio - Products, Competitors, Financials, Employees ...
Solareabio.com. Overview & Products; Financials; People; Founded Year 2017. Stage Series B …See details»
Solarea Bio, Inc. - VentureRadar
"The Solarea breakthrough came from the combined efforts of the company’s co-founders who …See details»
Contact Us - Solarea
For questions, collaborations, or further inquiries, please reach out to us at [email protected] or fill out the form.See details»
Solarea Bio, Inc.: Drug pipelines, Patents, Clinical trials - Synapse
Explore Solarea Bio, Inc. with its drug pipeline, therapeutic area, technology platform, 2 clinical …See details»
SOLAREA BIO INC Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for SOLAREA …See details»
Solarea Bio - Overview, News & Similar companies - ZoomInfo
Solarea Bio contact info: Phone number: (617) 955-3436 Website: www.solareabio.com What …See details»
Solarea Bio - Craft
Solarea Bio has 5 employees at their 1 location and $11.2 m in total funding,. See insights on …See details»
Solarea Bio Company Overview, Contact Details & Competitors
[email protected]: [email protected]: 3%. See more formats. Frequently …See details»
Solarea Bio - workinbiotech.com
Solarea Bio is unlocking a new source of microbes that can be used to improve human health. …See details»
Science - Solarea
January 1, 2022. The aim of the trial is to determine if the SYNBIOTIC (prebiotic and probiotic), …See details»
Solarea Bio Announces First Close of Series B Financing Round
May 9, 2023 Solarea Bio, a clinical stage biotechnology company based in Cambridge, MA …See details»
Solarea Bio rounds out management team to gear up for …
Oct 7, 2021 Solarea Bio started in 2017 with the hypothesis that one of the reasons fresh …See details»
Products - Solarea
Underway. SBD121 is currently being evaluated through a large randomized, double-blind, …See details»
Solarea Bio Announces First Close of Series B Financing Round
May 8, 2023 Solarea Bio, a clinical stage biotechnology company based in Cambridge, MA …See details»